tiprankstipranks
Organon (OGN)
NYSE:OGN
US Market
Want to see OGN full AI Analyst Report?

Organon (OGN) Blogger Opinions & Sentiment

1,124 Followers

Blogger Sentiment

Bullish: 83.33%
Sector Average
Bullish
OGN Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Organon: Deep Value With No Clear Catalysts
SeekingAlpha
The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products
SeekingAlpha
Organon: Muted H2 2025 Ahead, But Distressed Valuation And Manageable Debt Makes It A Compelling Buy
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of OGN?
Seeking Alpha’s Nivedita Hazra has a Bullish Sentiment.
    What do Motley Fool contributors think of OGN?
    Currently there's no blogger sentiment for OGN.
    What Is OGN’s Blogger Sentiment?
    OGN’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for OGN?
      The most recent blogger prediction for OGN was made by Nivedita Hazra, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited